原创公式规律四肖中特
GMP Production Facility


CGMP Production Facility

We are operating in a brand new facility, which allows HNSP to be one of the leading companies into the CGMP manufacture of bioactive peptides.
Our modern facility offers 5,700 square meters (613,542+ square feet) of production area and laboratories, for the CGMP manufacture of Sterile API Peptides, including lyophilization and packaging under sterile conditions. Six facilities have passed the CFDA CGMP audit (including two Peptide API facilities and four Lyophilized Injection facilties); Non-sterile API manufacturing facility received US FDA approval in 2013; Italian authority AIFA will inspect Thymalfasin API and FD in Jan/Feb 2016; US FDA may inspect Bivalirudin API and FD in 2016. Also, HNSP’s new production line for Cartridge formulations is ready for production. 
原创公式规律四肖中特 贵州十一选五开奖结果走势图 彩票刷流水是骗局吗 河南中原风采22选5尾数 广西快乐10分钟开奖结果 三木试点首页 福彩7加1多少钱一注 新时时彩什么时候开奖 倍投永不输本钱的方法 克莉丝汀欢乐生肖月饼 极速赛计划软件